“…Covalently attaching synthetic polymers to a protein, such as PEGylation, is one way to alter the bioactivity 2 , stability 3 , circulating half-life 4 , and immunogenicity 5 of the resultant protein–polymer conjugate. Polymer attachment site 6 , number of attachments 7,8 , polymer type 3,9 , polymer chain length 10,11 , and conjugation chemistry 12,13 are all variables that can be tuned to optimize the conjugate’s properties for a specific outcome, such as increased thermostability 14 or solubility. Protein solubility is especially important for therapeutic proteins, which can require concentrations as high as 100 mg/mL for effective dose administration.…”